Browse by Changes
Summary of Changes – 1 April 2019
Page last updated: 1 April 2019
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber Bag
- Additions
- Deletions
- Alterations
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Growth Hormone Program
- IVF Program
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Additions
Addition – Brand
| 3496B | Salbutamol Cipla, LR – SALBUTAMOL, salbutamol 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules |
| 3497C | Salbutamol Cipla, LR – SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules |
General Pharmaceutical Benefits
Additions
Addition – Item
| 11652G | ACICLOVIR, aciclovir 3% eye ointment, 4.5 g (AciVision) |
| 11654J | ACICLOVIR, aciclovir 3% eye ointment, 4.5 g (AciVision) |
| 11653H | AMINO ACID FORMULA WITH VITAMINS, MINERALS AND LONG CHAIN POLYUNSATURATED FATTY ACIDS WITHOUT PHENYLALANINE, amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine powder for oral liquid, 400 g (PKU Start) |
| 11663W | LEVODOPA + CARBIDOPA, levodopa 200 mg + carbidopa 50 mg modified release tablet, 100 (Carbidopa and Levodopa Extended-release Tablets) |
| 11655K | LEVODOPA + CARBIDOPA, levodopa 250 mg + carbidopa 25 mg tablet, 100 (Carbidopa and Levodopa Tablets, USP) |
| 11662T | RILUZOLE, riluzole 50 mg/10 mL oral liquid, 300 mL (Teglutik) |
| 11656L | SAFINAMIDE, safinamide 50 mg tablet, 30 (Xadago) |
| 11666B | SAFINAMIDE, safinamide 100 mg tablet, 30 (Xadago) |
| 11658N | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR, sofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28 (Vosevi) |
Addition – Brand
| 8879H | APO-Eplerenone, TX – EPLERENONE, eplerenone 25 mg tablet, 30 |
| 8880J | APO-Eplerenone, TX – EPLERENONE, eplerenone 50 mg tablet, 30 |
| 8399C | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 20 mg enteric tablet, 30 |
| 8007K | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
| 8008L | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
| 8787L | APO-Risperidone, TX – RISPERIDONE, risperidone 500 microgram tablet, 60 |
| 8869T | APO-Risperidone, TX – RISPERIDONE, risperidone 500 microgram tablet, 60 |
| 2000G | Salbutamol Cipla, LR – SALBUTAMOL, salbutamol 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules |
| 2001H | Salbutamol Cipla, LR – SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules |
Addition – Equivalence Indicator
| 1002R | Zovirax, GK – ACICLOVIR, aciclovir 3% eye ointment, 4.5 g |
| 5501M | Zovirax, GK – ACICLOVIR, aciclovir 3% eye ointment, 4.5 g |
| 1255C | Sinemet CR, MK – LEVODOPA + CARBIDOPA, levodopa 200 mg + carbidopa 50 mg modified release tablet, 100 |
| 1245M | Sinemet, MK – LEVODOPA + CARBIDOPA, levodopa 250 mg + carbidopa 25 mg tablet, 100 |
Addition – Note
| 10822N | AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS AND LONG CHAIN POLYUNSATURATED FATTY ACIDS WITHOUT PHENYLALANINE AND SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID, amino acid formula with fat, carbohydrate, vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine and supplemented with docosahexaenoic acid oral liquid, 20 x 500 mL bottles (PKU Baby) |
Addition – Restriction
| 9171Q | NILOTINIB, nilotinib 200 mg capsule, 120 (Tasigna) |
Deletions
Deletion – Brand
| 8362D | Xeloda, RO – CAPECITABINE, capecitabine 500 mg tablet, 120 |
| 3162K | Ranzepam, RA – DIAZEPAM, diazepam 5 mg tablet, 50 |
| 5072Y | Ranzepam, RA – DIAZEPAM, diazepam 5 mg tablet, 50 |
| 1978D | Ulcaid, RA – RANITIDINE, ranitidine 150 mg tablet, 60 |
| 8165R | Topiramate GH, GQ – TOPIRAMATE, topiramate 100 mg tablet, 60 |
| 9368C | APO-Valsartan, TX – VALSARTAN, valsartan 40 mg tablet, 28 |
| 9369D | APO-Valsartan, TX – VALSARTAN, valsartan 80 mg tablet, 28 |
| 9370E | APO-Valsartan, TX – VALSARTAN, valsartan 160 mg tablet, 28 |
| 9371F | APO-Valsartan, TX – VALSARTAN, valsartan 320 mg tablet, 28 |
Deletion – Equivalence Indicator
| 9368C | Diovan, NV – VALSARTAN, valsartan 40 mg tablet, 28 |
| 9369D | Diovan, NV – VALSARTAN, valsartan 80 mg tablet, 28 |
| 9370E | Diovan, NV – VALSARTAN, valsartan 160 mg tablet, 28 |
| 9371F | Diovan, NV – VALSARTAN, valsartan 320 mg tablet, 28 |
Deletion – Note
| 11264W | GEFITINIB, gefitinib 250 mg tablet, 30 (Iressa) |
| 8769M | GEFITINIB, gefitinib 250 mg tablet, 30 (Iressa) |
Deletion – Caution
| 8697R | ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Jr Mylan, EpiPen Jr.) |
| 8698T | ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Mylan, EpiPen) |
Alterations
Alteration – Item Description
| From | |
| 5502N | CARBOMER-974, carbomer-974 0.3% eye gel, 30 x 500 mg unit doses (Poly Gel) |
| To | |
| 5502N | CARBOMER-974P, carbomer-974P 0.3% eye gel, 30 x 500 mg unit doses (Poly Gel) |
| From | |
| 8514D | CARBOMER-974, carbomer-974 0.3% eye gel, 30 x 500 mg unit doses (Poly Gel) |
| To | |
| 8514D | CARBOMER-974P, carbomer-974P 0.3% eye gel, 30 x 500 mg unit doses (Poly Gel) |
| From | |
| 10104T | IRON, iron (as ferric carboxymaltose) 500 mg/10 mL injection, 1 x 10 mL vial (Ferinject) |
| To | |
| 10104T | FERRIC CARBOXYMALTOSE, iron (as ferric carboxymaltose) 500 mg/10 mL injection, 10 mL vial (Ferinject) |
| From | |
| 2765M | HALOPERIDOL DECANOATE, haloperidol (as decanoate) 50 mg/mL injection, 5 x 1 mL vials (Haldol decanoate) |
| To | |
| 2765M | HALOPERIDOL DECANOATE, haloperidol (as decanoate) 50 mg/mL injection, 5 x 1 mL ampoules (Haldol decanoate) |
| From | |
| 10250L | SUCROFERRIC OXYHYDROXIDE, iron (as sucroferric oxyhydroxide) 500 mg tablet: chewable, 90 (Velphoro) |
| To | |
| 10250L | IRON, sucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 (Velphoro) |
| From | |
| 10797G | PARACETAMOL, paracetamol 665 mg tablet: modified release, 192 (Osteomol 665 Paracetamol) |
| To | |
| 10797G | PARACETAMOL, paracetamol 665 mg modified release tablet, 192 (Osteomol 665 Paracetamol) |
| From | |
| 10218T | PEGINTERFERON BETA-1A, peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL injection device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL injection device], 1 pack (Plegridy) |
| To | |
| 10218T | PEGINTERFERON BETA-1A, peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL pen device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL pen device], 1 pack (Plegridy) |
Alteration – Note
| 11068M | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia ClickJect) |
| 11092T | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia ClickJect) |
| 1220F | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia) |
| 1221G | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia) |
| 8737W | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) |
| 8741C | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) |
| 9099X | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) |
| 9100Y | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) |
| 10922W | ARMODAFINIL, armodafinil 50 mg tablet, 30 (Nuvigil) |
| 10912H | ARMODAFINIL, armodafinil 150 mg tablet, 30 (Nuvigil) |
| 10919Q | ARMODAFINIL, armodafinil 250 mg tablet, 30 (Nuvigil) |
| 11437Y | BARICITINIB, baricitinib 2 mg tablet, 28 (Olumiant) |
| 11442F | BARICITINIB, baricitinib 2 mg tablet, 28 (Olumiant) |
| 11443G | BARICITINIB, baricitinib 4 mg tablet, 28 (Olumiant) |
| 11447L | BARICITINIB, baricitinib 4 mg tablet, 28 (Olumiant) |
| 10892G | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 10905Y | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 3425G | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 11321W | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11322X | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11325C | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11197H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8638P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11218K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys) |
| 11220M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel) |
| 9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel) |
| 9460X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel) |
| 11211C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 11219L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9090K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11372M | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
| 11375Q | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
| 3426H | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
| 3428K | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
| 8816B | MODAFINIL, modafinil 100 mg tablet, 60 (APO-Modafinil, Modafin, Modafinil AN, Modafinil Mylan, Modafinil Sandoz, Modavigil) |
| 10951J | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection) |
| 10954M | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection) |
| 11565Q | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (Actemra ACTPen) |
| 11567T | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (Actemra ACTPen) |
| 10511F | TOFACITINIB, tofacitinib 5 mg tablet, 56 (Xeljanz) |
| 10517M | TOFACITINIB, tofacitinib 5 mg tablet, 56 (Xeljanz) |
Alteration – Restriction
| 11068M | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia ClickJect) |
| 11092T | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia ClickJect) |
| 1220F | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia) |
| 1221G | ABATACEPT, abatacept 125 mg/mL injection, 4 x 1 mL syringes (Orencia) |
| 8737W | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) |
| 8741C | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) |
| 9099X | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) |
| 9100Y | ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) |
| 8697R | ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Jr Mylan, EpiPen Jr.) |
| 8698T | ADRENALINE (EPINEPHRINE), adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL pen device (Adrenaline Mylan, EpiPen) |
| 10922W | ARMODAFINIL, armodafinil 50 mg tablet, 30 (Nuvigil) |
| 10912H | ARMODAFINIL, armodafinil 150 mg tablet, 30 (Nuvigil) |
| 10919Q | ARMODAFINIL, armodafinil 250 mg tablet, 30 (Nuvigil) |
| 11437Y | BARICITINIB, baricitinib 2 mg tablet, 28 (Olumiant) |
| 11442F | BARICITINIB, baricitinib 2 mg tablet, 28 (Olumiant) |
| 11443G | BARICITINIB, baricitinib 4 mg tablet, 28 (Olumiant) |
| 11447L | BARICITINIB, baricitinib 4 mg tablet, 28 (Olumiant) |
| 10892G | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 10905Y | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 3425G | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
| 11321W | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11322X | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11325C | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
| 11197H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8638P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11220M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel) |
| 9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel) |
| 9460X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel) |
| 11219L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9090K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11372M | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
| 11375Q | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
| 3426H | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
| 3428K | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
| 11614G | GUSELKUMAB, guselkumab 100 mg/mL injection, 1 mL syringe (Tremfya) |
| 10918P | IMATINIB, imatinib 100 mg capsule, 60 (CIPLA IMATINIB ADULT, Glivanib, IMATINIB AN, IMATINIB-DRLA, Imatinib GH, Imatinib-APOTEX) |
| 10940T | IMATINIB, imatinib 100 mg capsule, 60 (CIPLA IMATINIB ADULT, Glivanib, IMATINIB AN, IMATINIB-DRLA, Imatinib GH, Imatinib-APOTEX) |
| 10921T | IMATINIB, imatinib 400 mg capsule, 30 (CIPLA IMATINIB ADULT, Glivanib, IMATINIB AN, IMATINIB-DRLA, Imatinib GH, Imatinib-APOTEX) |
| 10939R | IMATINIB, imatinib 400 mg capsule, 30 (CIPLA IMATINIB ADULT, Glivanib, IMATINIB AN, IMATINIB-DRLA, Imatinib GH, Imatinib-APOTEX) |
| 9176Y | IMATINIB, imatinib 100 mg tablet, 60 (Glivec, IMATINIB RBX, Imatinib-Teva) |
| 9178C | IMATINIB, imatinib 100 mg tablet, 60 (Glivec, IMATINIB RBX) |
| 9177B | IMATINIB, imatinib 400 mg tablet, 30 (Glivec, IMATINIB RBX, Imatinib-Teva) |
| 9179D | IMATINIB, imatinib 400 mg tablet, 30 (Glivec, IMATINIB RBX) |
| 8816B | MODAFINIL, modafinil 100 mg tablet, 60 (APO-Modafinil, Modafin, Modafinil AN, Modafinil Mylan, Modafinil Sandoz, Modavigil) |
| 8664B | RILUZOLE, riluzole 50 mg tablet, 56 (APO-Riluzole, Pharmacor Riluzole, Rilutek, Riluzole Sandoz) |
| 11613F | TILDRAKIZUMAB, tildrakizumab 100 mg/mL injection, 1 mL syringe (Ilumya) |
| 10951J | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection) |
| 10954M | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection) |
| 11565Q | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (Actemra ACTPen) |
| 11567T | TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (Actemra ACTPen) |
| 10511F | TOFACITINIB, tofacitinib 5 mg tablet, 56 (Xeljanz) |
| 10517M | TOFACITINIB, tofacitinib 5 mg tablet, 56 (Xeljanz) |
| 11624T | VENETOCLAX, venetoclax 10 mg tablet, 14 (Venclexta) |
| 11648C | VENETOCLAX, venetoclax 50 mg tablet, 7 (Venclexta) |
Alteration – Manufacturer Code
| From | To | ||
| 9454N | Oxytrol – OXYBUTYNIN, oxybutynin 3.9 mg/24 hours patch, 8 | GN | TT |
| 8481J | Actonel – RISEDRONATE, risedronate sodium 5 mg tablet, 28 | UA | TT |
| 8482K | Actonel – RISEDRONATE, risedronate sodium 30 mg tablet, 28 | UA | TT |
| 8972F | Actonel EC – RISEDRONATE, risedronate sodium 35 mg enteric tablet, 4 | UA | TT |
| 9391G | ATELVIA ONCE-A-MONTH – RISEDRONATE, risedronate sodium 150 mg tablet, 1 | GN | TU |
| 9391G | Actonel Once-a-Month – RISEDRONATE, risedronate sodium 150 mg tablet, 1 | UA | TT |
Advance Notices
1 May 2019
Deletion – Brand
| 8727H | XP Maxamum, SB – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE, amino acid formula with vitamins and minerals without phenylalanine powder for oral liquid, 30 x 50 g sachets |
| 2347M | Phlexy-10 Drink Mix, SB – AMINO ACID FORMULA WITHOUT PHENYLALANINE, amino acid formula without phenylalanine powder for oral liquid, 30 x 20 g sachets |
| 8554F | Phlexy-10, SB – AMINO ACID FORMULA WITHOUT PHENYLALANINE, amino acid formula without phenylalanine 500 mg capsule, 200 |
| 1210Q | Cifran, RA – CIPROFLOXACIN, ciprofloxacin 750 mg tablet, 14 |
| 8132B | Bonefos, BN – CLODRONATE, clodronate sodium 400 mg capsule, 100 |
| 8265B | Bonefos 800 mg, BN – CLODRONATE, clodronate sodium 800 mg tablet, 60 |
| 2850B | Lamotrigine generichealth, HQ – LAMOTRIGINE, lamotrigine 100 mg tablet, 56 |
| 2851C | Lamotrigine generichealth, HQ – LAMOTRIGINE, lamotrigine 200 mg tablet, 56 |
| 8679T | Lercanidipine GH, GQ – LERCANIDIPINE, lercanidipine hydrochloride 20 mg tablet, 28 |
| 1037N | Olanzapine generichealth 5, GQ – OLANZAPINE, olanzapine 5 mg tablet, 28 |
| 1042W | Olanzapine generichealth 10, GQ – OLANZAPINE, olanzapine 10 mg tablet, 28 |
| 11034R | Lynparza, AP – OLAPARIB, olaparib 50 mg capsule, 4 x 112 |
| 8399C | Pantoprazole GH, GQ – PANTOPRAZOLE, pantoprazole 20 mg enteric tablet, 30 |
| 5527X | Vistil, AE – POLYVINYL ALCOHOL, polyvinyl alcohol 1.4% eye drops, 15 mL |
| 5528Y | Vistil Forte, AE – POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL |
| 8831T | Vistil, AE – POLYVINYL ALCOHOL, polyvinyl alcohol 1.4% eye drops, 15 mL |
| 8832W | Vistil Forte, AE – POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL |
| 9221H | Vistil, AE – POLYVINYL ALCOHOL, polyvinyl alcohol 1.4% eye drops, 15 mL |
| 9223K | Vistil Forte, AE – POLYVINYL ALCOHOL, polyvinyl alcohol 3% eye drops, 15 mL |
| 5261X | Roxithromycin GH, GQ – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
| 8016X | Roxithromycin GH, GQ – ROXITHROMYCIN, roxithromycin 300 mg tablet, 5 |
1 June 2019
Deletion – Brand
| 2518M | Emend, MK – APREPITANT, aprepitant 165 mg capsule, 1 |
| 3138E | Clindamycin-Link, LI – CLINDAMYCIN, clindamycin 150 mg capsule, 24 |
| 5057E | Clindamycin-Link, LI – CLINDAMYCIN, clindamycin 150 mg capsule, 24 |
| 9164H | Cystine 500, VF – CYSTINE WITH CARBOHYDRATE, cystine with carbohydrate containing 500 mg cystine oral liquid: powder for, 30 x 4 g sachets |
| 1280J | Hydrene 25/50, AF – HYDROCHLOROTHIAZIDE + TRIAMTERENE, hydrochlorothiazide 25 mg + triamterene 50 mg tablet, 100 |
| 5132D | Dilaudid, MF – HYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL |
| 8424J | Dilaudid, MF – HYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL |
1 July 2019
Deletion – Brand
| 8048N | ReoPro, JC – ABCIXIMAB, abciximab 10 mg/5 mL injection, 5 mL vial |
| 2738D | XP Maxamaid, SB – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE, amino acid formula with vitamins and minerals without phenylalanine powder for oral liquid, 500 g |
| 8726G | Copaxone, TB – GLATIRAMER ACETATE, glatiramer acetate 20 mg/mL injection, 28 x 1 mL syringes |
| 9059T | Avandamet, GK – ROSIGLITAZONE + METFORMIN, rosiglitazone 2 mg + metformin hydrochloride 500 mg tablet, 56 |
| 9060W | Avandamet, GK – ROSIGLITAZONE + METFORMIN, rosiglitazone 2 mg + metformin hydrochloride 1 g tablet, 56 |
| 9061X | Avandamet, GK – ROSIGLITAZONE + METFORMIN, rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet, 56 |
| 9062Y | Avandamet, GK – ROSIGLITAZONE + METFORMIN, rosiglitazone 4 mg + metformin hydrochloride 1 g tablet, 56 |
1 August 2019
Deletion – Brand
| 2946C | Phosphate Sandoz, FF – PHOSPHORUS, phosphorus 500 mg effervescent tablet, 100 |
1 September 2019
Deletion – Brand
| 1923F | MMA/PA cooler 15, VF – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT METHIONINE, THREONINE AND VALINE AND LOW IN ISOLEUCINE, amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine oral liquid, 30 x 130 mL pouches |
| 1711C | Hypurin Isophane, AS – INSULIN ISOPHANE BOVINE, insulin isophane bovine 100 units/mL injection, 1 x 10 mL vial |
| 1713E | Hypurin Neutral, AS – INSULIN NEUTRAL BOVINE, insulin neutral bovine 100 units/mL injection, 1 x 10 mL vial |
1 October 2019
Deletion – Brand
| 2544X | Akineton, GH – BIPERIDEN, biperiden hydrochloride 2 mg tablet, 100 |
1 December 2019
Deletion – Brand
| 1002R | Zovirax, GK – ACICLOVIR, aciclovir 3% eye ointment, 4.5 g |
| 5501M | Zovirax, GK – ACICLOVIR, aciclovir 3% eye ointment, 4.5 g |
1 January 2020
Deletion – Brand
| 8362D | Capecitabine Apotex, TX – CAPECITABINE, capecitabine 500 mg tablet, 120 |
Palliative Care
Deletions
Deletion – Brand
| 5356X | Ranzepam, RA – DIAZEPAM, diazepam 5 mg tablet, 50 |
Alterations
Alteration – Item Description
| From | |
| 10796F | PARACETAMOL, paracetamol 665 mg tablet: modified release, 192 (Osteomol 665 Paracetamol) |
| To | |
| 10796F | PARACETAMOL, paracetamol 665 mg modified release tablet, 192 (Osteomol 665 Paracetamol) |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
| 11659P | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR, sofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28 (Vosevi) |
Alterations
Alteration – Item Description
| From | |
| 10230K | SUCROFERRIC OXYHYDROXIDE, iron (as sucroferric oxyhydroxide) 500 mg tablet: chewable, 90 (Velphoro) |
| To | |
| 10230K | IRON, sucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 (Velphoro) |
Alteration – Note
| 9621J | ABATACEPT, abatacept 250 mg injection, 1 vial (Orencia) |
| 11483J | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
| 11487N | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Remicade) |
| 6397Q | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
| 9611W | RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial (Mabthera) |
| 9671B | TOCILIZUMAB, tocilizumab 80 mg/4 mL injection, 4 mL vial (Actemra) |
| 9672C | TOCILIZUMAB, tocilizumab 200 mg/10 mL injection, 10 mL vial (Actemra) |
| 9673D | TOCILIZUMAB, tocilizumab 400 mg/20 mL injection, 20 mL vial (Actemra) |
Alteration – Restriction
| 9621J | ABATACEPT, abatacept 250 mg injection, 1 vial (Orencia) |
| 5830W | FILGRASTIM, filgrastim 120 microgram/0.2 mL injection, 10 x 0.2 mL syringes (Nivestim) |
| 1082Y | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (TevaGrastim) |
| 2747N | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio) |
| 6291D | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Neupogen) |
| 9693E | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim) |
| 6126K | FILGRASTIM, filgrastim 300 microgram/mL injection, 10 x 1 mL vials (Neupogen) |
| 2733W | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio) |
| 6292E | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Neupogen) |
| 9695G | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim) |
| 1113N | FILGRASTIM, filgrastim 480 microgram/0.8 mL injection, 10 x 0.8 mL syringes (TevaGrastim) |
| 6127L | FILGRASTIM, filgrastim 480 microgram/1.6 mL injection, 10 x 1.6 mL vials (Neupogen) |
| 11483J | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
| 11487N | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Remicade) |
| 6397Q | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
| 9611W | RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial (Mabthera) |
| 9671B | TOCILIZUMAB, tocilizumab 80 mg/4 mL injection, 4 mL vial (Actemra) |
| 9672C | TOCILIZUMAB, tocilizumab 200 mg/10 mL injection, 10 mL vial (Actemra) |
| 9673D | TOCILIZUMAB, tocilizumab 400 mg/20 mL injection, 20 mL vial (Actemra) |
Alteration – Restriction Level
| From | To | ||
| 5830W | FILGRASTIM, filgrastim 120 microgram/0.2 mL injection, 10 x 0.2 mL syringes (Nivestim) | authority-required | streamlined |
| 1082Y | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (TevaGrastim) | authority-required | streamlined |
| 2747N | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio) | authority-required | streamlined |
| 6291D | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Neupogen) | authority-required | streamlined |
| 9693E | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim) | authority-required | streamlined |
| 6126K | FILGRASTIM, filgrastim 300 microgram/mL injection, 10 x 1 mL vials (Neupogen) | authority-required | streamlined |
| 2733W | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio) | authority-required | streamlined |
| 6292E | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Neupogen) | authority-required | streamlined |
| 9695G | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim) | authority-required | streamlined |
| 1113N | FILGRASTIM, filgrastim 480 microgram/0.8 mL injection, 10 x 0.8 mL syringes (TevaGrastim) | authority-required | streamlined |
| 6127L | FILGRASTIM, filgrastim 480 microgram/1.6 mL injection, 10 x 1.6 mL vials (Neupogen) | authority-required | streamlined |
Advance Notices
1 May 2019
Deletion – Brand
| 11232E | Exjade, NV – DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 |
| 11236J | Exjade, NV – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 |
| 11238L | Exjade, NV – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 |
| 11241P | Exjade, NV – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 |
| 11243R | Exjade, NV – DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 |
| 11244T | Exjade, NV – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 |
| 6499C | Exjade, NV – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 |
| 6500D | Exjade, NV – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 |
| 9600G | Exjade, NV – DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 |
1 June 2019
Deletion – Brand
| 1082Y | TevaGrastim, TB – FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes |
| 1113N | TevaGrastim, TB – FILGRASTIM, filgrastim 480 microgram/0.8 mL injection, 10 x 0.8 mL syringes |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
| 11665Y | SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR, sofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28 (Vosevi) |
Alterations
Alteration – Item Description
| From | |
| 10233N | SUCROFERRIC OXYHYDROXIDE, iron (as sucroferric oxyhydroxide) 500 mg tablet: chewable, 90 (Velphoro) |
| To | |
| 10233N | IRON, sucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 (Velphoro) |
Alteration – Note
| 5605B | ABATACEPT, abatacept 250 mg injection, 1 vial (Orencia) |
| 11481G | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Remicade) |
| 11490R | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
| 5757B | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
| 9544H | RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial (Mabthera) |
| 9657G | TOCILIZUMAB, tocilizumab 80 mg/4 mL injection, 4 mL vial (Actemra) |
| 9658H | TOCILIZUMAB, tocilizumab 200 mg/10 mL injection, 10 mL vial (Actemra) |
| 9659J | TOCILIZUMAB, tocilizumab 400 mg/20 mL injection, 20 mL vial (Actemra) |
Alteration – Restriction
| 5605B | ABATACEPT, abatacept 250 mg injection, 1 vial (Orencia) |
| 1123D | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (TevaGrastim) |
| 5742F | FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Neupogen) |
| 5741E | FILGRASTIM, filgrastim 300 microgram/mL injection, 10 x 1 mL vials (Neupogen) |
| 5744H | FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Neupogen) |
| 1126G | FILGRASTIM, filgrastim 480 microgram/0.8 mL injection, 10 x 0.8 mL syringes (TevaGrastim) |
| 5743G | FILGRASTIM, filgrastim 480 microgram/1.6 mL injection, 10 x 1.6 mL vials (Neupogen) |
| 11481G | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Remicade) |
| 11490R | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis) |
| 5757B | INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis) |
| 9544H | RITUXIMAB, rituximab 500 mg/50 mL injection, 50 mL vial (Mabthera) |
| 9657G | TOCILIZUMAB, tocilizumab 80 mg/4 mL injection, 4 mL vial (Actemra) |
| 9658H | TOCILIZUMAB, tocilizumab 200 mg/10 mL injection, 10 mL vial (Actemra) |
| 9659J | TOCILIZUMAB, tocilizumab 400 mg/20 mL injection, 20 mL vial (Actemra) |
Advance Notices
1 May 2019
Deletion – Brand
| 11231D | Exjade, NV – DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 |
| 11234G | Exjade, NV – DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 |
| 11235H | Exjade, NV – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 |
| 11239M | Exjade, NV – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 |
| 11240N | Exjade, NV – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 |
| 11247Y | Exjade, NV – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 |
| 5654N | Exjade, NV – DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 |
| 5655P | Exjade, NV – DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 |
| 5656Q | Exjade, NV – DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 |
1 June 2019
Deletion – Brand
| 1123D | TevaGrastim, TB – FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes |
| 1126G | TevaGrastim, TB – FILGRASTIM, filgrastim 480 microgram/0.8 mL injection, 10 x 0.8 mL syringes |
Highly Specialised Drugs Program (Community Access)
Additions
Addition – Item
| 11657M | ATAZANAVIR, atazanavir 300 mg capsule, 60 (Atazanavir Mylan) |
Addition – Brand
| 10349Q | Atazanavir Mylan, AF – ATAZANAVIR, atazanavir 200 mg capsule, 60 |
Addition – Equivalence Indicator
| 10349Q | Reyataz, BQ – ATAZANAVIR, atazanavir 200 mg capsule, 60 |
| 10321F | Reyataz, BQ – ATAZANAVIR, atazanavir 300 mg capsule, 30 |
Addition – Note
| 10321F | ATAZANAVIR, atazanavir 300 mg capsule, 30 (Reyataz) |
Alterations
Alteration – Item Description
| From | |
| 10279B | ENTECAVIR, entecavir monohydrate 500 microgram tablet, 30 (Baraclude, ENTAC, ENTECAVIR RBX, ENTECLUDE, Entecavir APOTEX, Entecavir Amneal, Entecavir GH, Entecavir Mylan, Entecavir Sandoz) |
| To | |
| 10279B | ENTECAVIR, entecavir 500 microgram tablet, 30 (Baraclude, ENTAC, ENTECAVIR RBX, ENTECLUDE, Entecavir APOTEX, Entecavir Amneal, Entecavir GH, Entecavir Mylan, Entecavir Sandoz) |
| From | |
| 10353X | ENTECAVIR, entecavir monohydrate 1 mg tablet, 30 (Baraclude, ENTAC, ENTECAVIR RBX, ENTECLUDE, Entecavir APOTEX, Entecavir Amneal, Entecavir GH, Entecavir Mylan, Entecavir Sandoz) |
| To | |
| 10353X | ENTECAVIR, entecavir 1 mg tablet, 30 (Baraclude, ENTAC, ENTECAVIR RBX, ENTECLUDE, Entecavir APOTEX, Entecavir Amneal, Entecavir GH, Entecavir Mylan, Entecavir Sandoz) |
Advance Notices
1 January 2020
Deletion – Brand
| 10357D | Abacavir/Lamivudine 600/300 APOTEX, TX – ABACAVIR + LAMIVUDINE, abacavir 600 mg + lamivudine 300 mg tablet, 30 |
Growth Hormone Program
Additions
Addition – Item
| 11650E | SOMATROPIN, somatropin 10 mg/2 mL injection, 2 mL cartridge (NutropinAq) |
IVF Program
Additions
Addition – Item
| 11667C | FOLLITROPIN ALFA + LUTROPIN ALFA, follitropin alfa 900 units (65.52 microgram)/1.44 mL + lutropin alfa 450 units/1.44 mL injection, 1.44 mL pen device (Pergoveris) |
Repatriation Pharmaceutical Benefits
Alterations
Alteration – Item Description
| From | |
| 4518T | GELATIN + PECTIN + CARMELLOSE SODIUM, carmellose sodium 16.7% + gelatin 16.7% + pectin 16.7% oromucosal paste, 5 g (Orabase) |
| To | |
| 4518T | GELATIN + PECTIN + CARMELLOSE SODIUM, gelatin 16.7% + pectin 16.7% + carmellose sodium 16.7% paste, 5 g (Orabase) |
Alteration – Manufacturer Code
| From | To | ||
| 4443W | Actonel – RISEDRONATE, risedronate sodium 5 mg tablet, 28 | UA | TT |
| 2191H | Actonel EC – RISEDRONATE, risedronate sodium 35 mg enteric tablet, 4 | UA | TT |
Advance Notices
1 May 2019
Deletion – Brand
| 4010C | Sandoz Nail Repair, SZ – AMOROLFINE, amorolfine 5% application, 5 mL |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
| 11651F |
BRENTUXIMAB VEDOTIN, brentuximab vedotin 50 mg injection, 1 vial (Adcetris) |
| 11661R |
BRENTUXIMAB VEDOTIN, brentuximab vedotin 50 mg injection, 1 vial (Adcetris) |
Deletions
Deletion – Brand
| 7231N | Epirubicin SZ, HX – EPIRUBICIN, epirubicin hydrochloride 50 mg/25 mL injection, 25 mL vial |
Deletion – Note
| 10069Y |
PANITUMUMAB, panitumumab 100 mg/5 mL injection, 5 mL vial (Vectibix); panitumumab 400 mg/20 mL injection, 20 mL vial (Vectibix) |
Advance Notices
1 September 2019
Deletion – Brand
| 10237T | Arzerra, NV – OFATUMUMAB, ofatumumab 1 g/50 mL injection, 50 mL vial |
| 10239X | Arzerra, NV – OFATUMUMAB, ofatumumab 1 g/50 mL injection, 50 mL vial |
| 10240Y | Arzerra, NV – OFATUMUMAB, ofatumumab 100 mg/5 mL injection, 3 x 5 mL vials |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
| 11660Q |
BRENTUXIMAB VEDOTIN, brentuximab vedotin 50 mg injection, 1 vial (Adcetris) |
| 11664X |
BRENTUXIMAB VEDOTIN, brentuximab vedotin 50 mg injection, 1 vial (Adcetris) |
Deletions
Deletion – Brand
| 4375G | Epirubicin SZ, HX – EPIRUBICIN, epirubicin hydrochloride 50 mg/25 mL injection, 25 mL vial |
Advance Notices
1 September 2019
Deletion – Brand
| 10236R | Arzerra, NV – OFATUMUMAB, ofatumumab 1 g/50 mL injection, 50 mL vial |
| 10249K | Arzerra, NV – OFATUMUMAB, ofatumumab 100 mg/5 mL injection, 3 x 5 mL vials |
| 10252N | Arzerra, NV – OFATUMUMAB, ofatumumab 1 g/50 mL injection, 50 mL vial |
Related Pharmaceutical Benefits for Public Hospital use
Advance Notices
1 June 2019
Deletion – Brand
| 2550F | Emend, MK – APREPITANT, aprepitant 165 mg capsule, 1 |
